Status:
COMPLETED
Effects of L-Citrulline or Citrulline-malate on Neuromuscular Performance in Resistance-trained Adults
Lead Sponsor:
Universidad de Granada
Conditions:
Neuromuscular Performance
Eligibility:
All Genders
18-35 years
Phase:
NA
Brief Summary
The main aim of this study is to compare the effects of L-Citrulline vs. Citrulline-malate on neuromuscular performance (maximal dynamic strength and maximal endurance strength) in resistance-trained ...
Detailed Description
Nitric oxide (NO) is a ubiquitous gaseous molecule that plays a critical role in the regulation of cardiovascular function and in the signaling of multiple cellular processes. Specifically, NO could r...
Eligibility Criteria
Inclusion
- Healthy male or female
- Ages 18-30years
- BMI: 18-30.0 kg/m2
- Stable weight over the last 3 months (body weight changes\<3kg)
- Previous experience in resistance training (i.e., at least 1 year with a frequency of two or more training sessions per week),
- Participant must be capable and willing to provide consent, understand exclusion criteria, instructions and protocols.
Exclusion
- History of chronic diseases (renal disease, diabetes, cardiovascular disease, cancer, VIH, hepatic disease, food disorders)
- Pregnant, planning to become pregnant, or breastfeeding
- Have been treated previously or during the study period with prescription drugs:
- antihypertensive, lipid lowering, acid uric lowering, glucose lowering, beta blockers or any drug that under the investigator's judged could influence the results.
- Allergy/intolerance to any ingredient of the dietary supplements.
- Chronic consumers of dietary NO-precursors dietary supplements (citrulline malate, arginine, nitrates).
- Any non-controlled medical condition which could influence results or could be worsened by the participation in the study.
- Are deemed unsuitable by the investigator for any other reason, that prevent data collection.
Key Trial Info
Start Date :
February 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2022
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05183893
Start Date
February 15 2022
End Date
June 30 2022
Last Update
November 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jonatan Ruiz Ruiz
Granada, Spain, 18011